With a focus on advocating for pharmacies and other healthcare providers, Morgan handles various legal matters, including disputes with Pharmacy Benefit Managers (PBMs) and other third-party payors, including Medicare and Medicaid. He also regularly navigates administrative and regulatory matters, including frequently handling state Board of Pharmacy (BOP) matters. Matters with BOPs involve various legal issues, including advising and representing clients in BOP licensing, inspections, investigations, enforcement actions, and other related matters across many jurisdictions nationwide.
"We are dedicated to growing our life sciences services. Lucas is a strategic addition to our section who deepens our bench and enhances value to clients," said Barbara Binzak Blumenfeld, chair of the FDA & Biotechnology section. "We are excited to see what he will achieve at Buchanan and for our clients."
"Buchanan's impressive life sciences lawyers and its national platform made it the right fit for me to best serve my clients and continue to grow my practice," said Morgan.
Morgan also handles complex disputes involving PBMs, including audit disputes and network access issues, and in litigation or arbitration, when necessary. His in-depth understanding of the highly consolidated PBM marketplace, which is dominated by a small number of powerful corporations, allows him to counsel independent pharmacy owners and operators on developing successful strategies for navigating this unique environment.
Morgan often speaks at industry events and is a frequent author of alerts and articles for various publications and trade associations. He has been selected for Rising Stars by Super Lawyers since 2020.
Morgan is the latest addition to the firm's Pharmacy Benefit Manager Contract & Audit Defense practice group, which started when Dae Lee, Pharm.D., Esq., CPBS joined Buchanan in January 2025. The group provides strategic counsel for both plan sponsors and pharmacies that helps to mitigate risk and protect the interests of their businesses.